Annual CFI
$78.04 M
+$253.82 M+144.40%
31 December 2023
Summary:
Repare Therapeutics annual cash flow from investing activities is currently $78.04 million, with the most recent change of +$253.82 million (+144.40%) on 31 December 2023. During the last 3 years, it has risen by +$87.80 million (+899.35%). RPTX annual CFI is now at all-time high.RPTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$31.08 M
+$23.96 M+336.64%
30 September 2024
Summary:
Repare Therapeutics quarterly cash flow from investing activities is currently $31.08 million, with the most recent change of +$23.96 million (+336.64%) on 30 September 2024. Over the past year, it has increased by +$6.58 million (+26.87%). RPTX quarterly CFI is now -8.74% below its all-time high of $34.06 million, reached on 31 December 2022.RPTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$49.76 M
+$6.58 M+15.24%
30 September 2024
Summary:
Repare Therapeutics TTM cash flow from investing activities is currently $49.76 million, with the most recent change of +$6.58 million (+15.24%) on 30 September 2024. Over the past year, it has dropped by -$30.46 million (-37.97%). RPTX TTM CFI is now -37.97% below its all-time high of $80.22 million, reached on 30 September 2023.RPTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +144.4% | +26.9% | -38.0% |
| 3 y3 years | +899.4% | +8089.7% | +572.8% |
| 5 y5 years | +10000.0% | +10000.0% | +8970.0% |
RPTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +144.4% | -8.7% | +114.9% | -38.0% | +123.7% |
| 5 y | 5 years | at high | +144.4% | -8.7% | +114.9% | -38.0% | +123.7% |
| alltime | all time | at high | +144.4% | -8.7% | +114.9% | -38.0% | +123.7% |
Repare Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $31.08 M(+336.6%) | $49.76 M(+15.2%) |
| June 2024 | - | $7.12 M(-135.0%) | $43.18 M(-33.0%) |
| Mar 2024 | - | -$20.32 M(-163.7%) | $64.41 M(-17.5%) |
| Dec 2023 | $78.04 M(-144.4%) | $31.88 M(+30.1%) | $78.04 M(-2.7%) |
| Sept 2023 | - | $24.50 M(-13.6%) | $80.22 M(-152.4%) |
| June 2023 | - | $28.35 M(-524.0%) | -$153.21 M(-16.2%) |
| Mar 2023 | - | -$6.69 M(-119.6%) | -$182.87 M(+4.0%) |
| Dec 2022 | -$175.78 M(>+9900.0%) | $34.06 M(-116.3%) | -$175.78 M(-16.4%) |
| Sept 2022 | - | -$208.93 M(>+9900.0%) | -$210.23 M(>+9900.0%) |
| June 2022 | - | -$1.31 M(-424.8%) | -$1.69 M(+237.9%) |
| Mar 2022 | - | $403.00 K(-201.3%) | -$501.00 K(-70.1%) |
| Dec 2021 | -$1.68 M | -$398.00 K(+2.3%) | -$1.68 M(-84.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$389.00 K(+232.5%) | -$10.53 M(-0.8%) |
| June 2021 | - | -$117.00 K(-84.8%) | -$10.61 M(+1.0%) |
| Mar 2021 | - | -$772.00 K(-91.7%) | -$10.51 M(+7.6%) |
| Dec 2020 | -$9.76 M(+648.7%) | -$9.25 M(+1855.0%) | -$9.76 M(+675.5%) |
| Sept 2020 | - | -$473.00 K(+3538.5%) | -$1.26 M(+30.2%) |
| June 2020 | - | -$13.00 K(-56.7%) | -$967.00 K(-22.9%) |
| Mar 2020 | - | -$30.00 K(-96.0%) | -$1.25 M(-3.8%) |
| Dec 2019 | -$1.30 M(+123.7%) | -$743.00 K(+310.5%) | -$1.30 M(+132.4%) |
| Sept 2019 | - | -$181.00 K(-39.7%) | -$561.00 K(+47.6%) |
| June 2019 | - | -$300.00 K(+275.0%) | -$380.00 K(+375.0%) |
| Mar 2019 | - | -$80.00 K | -$80.00 K |
| Dec 2018 | -$583.00 K(-49.6%) | - | - |
| Dec 2017 | -$1.16 M | - | - |
FAQ
- What is Repare Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Repare Therapeutics?
- What is Repare Therapeutics annual CFI year-on-year change?
- What is Repare Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Repare Therapeutics?
- What is Repare Therapeutics quarterly CFI year-on-year change?
- What is Repare Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Repare Therapeutics?
- What is Repare Therapeutics TTM CFI year-on-year change?
What is Repare Therapeutics annual cash flow from investing activities?
The current annual CFI of RPTX is $78.04 M
What is the all time high annual CFI for Repare Therapeutics?
Repare Therapeutics all-time high annual cash flow from investing activities is $78.04 M
What is Repare Therapeutics annual CFI year-on-year change?
Over the past year, RPTX annual cash flow from investing activities has changed by +$253.82 M (+144.40%)
What is Repare Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RPTX is $31.08 M
What is the all time high quarterly CFI for Repare Therapeutics?
Repare Therapeutics all-time high quarterly cash flow from investing activities is $34.06 M
What is Repare Therapeutics quarterly CFI year-on-year change?
Over the past year, RPTX quarterly cash flow from investing activities has changed by +$6.58 M (+26.87%)
What is Repare Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RPTX is $49.76 M
What is the all time high TTM CFI for Repare Therapeutics?
Repare Therapeutics all-time high TTM cash flow from investing activities is $80.22 M
What is Repare Therapeutics TTM CFI year-on-year change?
Over the past year, RPTX TTM cash flow from investing activities has changed by -$30.46 M (-37.97%)